About Aptahem
Business Strategy
Business Model
History
Team
Portfolio
RNA-therapeutics
Apta-1
Apta-2
Apta-3
Intellectual Property and Patent
Our Research
Scientific Collaborations
Örebro Consortium
Seattle Children’s Research Institute (SCRI)
University Health Network (UHN)
Publications
Production
Mechanism of Action
About Sepsis
Investor
Market Potential
Company Information
Share information
General Meetings
Largest Owners
Financial Reports
Annual Reports
Interim Reports
Financial Calendar
Events
Share issues
Analyzes
Media
News
Newsletter
Presentations
Sepsis Seminar 2021
Contact
Nov
29
2024
Interim Report Q3 2024
Financial Calendar
Start date:
2024-11-29
End date:
2024-11-29
